Plus Therapeutics, Inc.
(NASDAQ: PSTV)

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

0.655

+0.058 (+9.72%)
Range 0.600 - 0.660   (10%)
Open 0.600
Previous Close 0.597
Bid Price 3.910
Bid Volume 10
Ask Price 3.950
Ask Volume 12
Volume 9,067,980
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis